Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

Share Price is delayed by 15 minutes
Get Live Data
8.65    0.00 (0.00%)
Bid:
8.30
Ask:
9.00
Spread: 0.70 (8.434%)
Market Cap: £56.68m
KMK Live PriceLast checked at - London Stock Exchange

Intraday Kromek Share Chart

Sole source supplier contract from DARPA

22 Feb 2016 07:00

RNS Number : 6741P
Kromek Group PLC
22 February 2016
 

 

Approved for Public Release, Distribution Unlimited

22 February 2016

Kromek Group plc

("Kromek" or the "Company")

 

Kromek Signs Second contract with DARPA

US defence agency appoints Kromek as sole source supplier under SIGMA programme to deliver D3S detectors in mass volume

 

Further to the announcement of 8 October 2015, Kromek, a radiation detection technology company focusing on the medical, security and nuclear markets, announces that the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense, has confirmed the award of a sole source contract to Kromek to supply spectroscopic personal radiation detectors (D3S) in support of DARPA's SIGMA programme. The contract also includes an additional award for an accessory for the D3S. The total value of the contract is $6.0m with delivery commencing immediately.

 

Under the terms of the contract, Kromek will deliver the D3S detectors during the current and next financial year and will also supply up to 12,000 Inductive Charging packs for D3S detectors and associated mobile devices over the same period. The Inductive Charging pack has an innovative deployable capability for high volume daily usage of the detectors and the methodology for both charging and recalibrating where necessary.

 

Arnab Basu, Chief Executive Officer of Kromek, said: "The D3S is the world's first fully approved combined gamma and neutron detector available in volume shipment and at a market leading unit price of $400, which is also available to other user organisations buying over 10,000 detectors in a single procurement. It is a significant breakthrough for us and we are pleased to have achieved the technological advancement that has enabled DARPA to be ahead of their own original programme performance expectations. We look forward to successfully delivering on the contract."

 

 

Enquiries:

 

Kromek Group plc

01740 626 060

Arnab Basu, CEO

Derek Bulmer, CFO

 

 

 

Cenkos Securities plc

0207 397 8900

Bobbie Hilliam (NOMAD)

Julian Morse, Michael Johnson (Sales)

 

 

 

Luther Pendragon Ltd

0207 618 9100

Harry Chathli, Claire Norbury, Alexis Gore

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGGGDDCGDBGLD
Date   Source Headline
8th Dec 20207:00 amRNSContract extensions for D3S products
3rd Dec 20207:00 amRNSKromek launches the D5 RIID radiation detector
2nd Nov 20207:00 amRNSKromek wins new sector-leading global OEM customer
2nd Nov 20207:00 amRNSResult of AGM
29th Oct 20207:00 amRNSDirectorate Change
14th Oct 20207:00 amRNSKromek CZT technology to improve cancer surgery
9th Oct 20204:41 pmRNSSecond Price Monitoring Extn
9th Oct 20204:36 pmRNSPrice Monitoring Extension
8th Oct 20205:28 pmRNSHolding(s) in Company
8th Oct 20204:44 pmRNSNotice of AGM and Publication of Annual Report
8th Oct 202012:58 pmRNSDirector Share Purchase
8th Oct 20207:00 amRNSAppointment of Non-executive Director
7th Oct 202011:13 amRNSDirector Share Purchase
7th Oct 202011:00 amRNSPrice Monitoring Extension
7th Oct 20207:00 amRNSFinal Results
28th Sep 20203:00 pmRNSHolding(s) in Company
17th Sep 20201:53 pmRNSHolding(s) in Company
27th May 20207:00 amRNSKromek awarded new DARPA bio-surveillance contract
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
1st May 20209:05 amRNSSecond Price Monitoring Extn
1st May 20209:00 amRNSPrice Monitoring Extension
1st May 20207:00 amRNSFull Year Trading Update and Response to COVID-19
27th Apr 202010:57 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSKromek receives Queen’s Award
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
16th Apr 20202:00 pmRNSPrice Monitoring Extension
15th Apr 20207:00 amRNSKromek to produce ventilators to fight COVID-19
20th Mar 202010:52 amRNSHolding(s) in Company
18th Feb 20204:15 pmRNSHolding(s) in Company
27th Jan 202012:42 pmRNSSite visit by International Trade Secretary
9th Jan 20204:55 pmRNSHolding(s) in Company
27th Dec 20197:00 amRNSHolding(s) in Company
17th Dec 20197:00 amRNSDirector Share Purchase
12th Dec 20197:00 amRNSDirector Share Purchases
11th Dec 20197:00 amRNSInterim Results
5th Dec 20197:00 amRNSNotice of Results
4th Dec 20195:25 pmRNSHolding(s) in Company
26th Sep 20191:14 pmRNSResult of AGM
24th Sep 20197:00 amRNSKromek awarded two contracts for D3S products
30th Aug 20191:50 pmRNSNotice of AGM and Publication of Annual Report
1st Jul 20197:00 amRNSNew contracts for D3S in UK, US and Europe
27th Jun 20197:00 amRNSFinal Results
7th May 20197:00 amRNSTrading Update
1st May 20197:00 amRNSSecurity screening contract order expansion
29th Mar 20194:51 pmRNSChange of Adviser
18th Mar 20195:50 pmRNSDirector Dealings Correction
28th Feb 20191:00 pmRNSHolding(s) in Company
28th Feb 20191:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.